3428 related articles for article (PubMed ID: 7597290)
1. Prognostic significance of DNA cytometry in comparison with histologic measurements in malignant melanomas.
Vogt T; Stolz W; Hohenleutner U; Schiffner R; Landthaler M
Recent Results Cancer Res; 1995; 139():195-204. PubMed ID: 7597290
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA cytometry in cutaneous malignant lymphomas.
Vogt T; Stolz W; Braun-Falco O; Kaudewitz P; Eckert F; Abmayr W; Dummer R; Burg G
Cancer; 1991 Sep; 68(5):1095-100. PubMed ID: 1913480
[TBL] [Abstract][Full Text] [Related]
3. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens.
Stolz W; Vogt T; Landthaler M; Hempfer S; Bingler P; Abmayr W
J Cutan Pathol; 1994 Feb; 21(1):7-15. PubMed ID: 8188937
[TBL] [Abstract][Full Text] [Related]
6. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
8. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
Klapperstück T; Wohlrab W
Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
10. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
Bedin V; Adam RL; de Sá BC; Landman G; Metze K
BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
[TBL] [Abstract][Full Text] [Related]
11. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
[TBL] [Abstract][Full Text] [Related]
13. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
[TBL] [Abstract][Full Text] [Related]
14. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact.
Sørensen FB; Kristensen IB; Grymer F; Jakobsen A
Am J Dermatopathol; 1991 Feb; 13(1):11-9. PubMed ID: 2003643
[TBL] [Abstract][Full Text] [Related]
15. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
[TBL] [Abstract][Full Text] [Related]
16. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
[TBL] [Abstract][Full Text] [Related]
17. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
Lindholm C; Hofer PA; Jonsson H
Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
[TBL] [Abstract][Full Text] [Related]
18. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
[TBL] [Abstract][Full Text] [Related]
19. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
von Roenn JH; Kheir SM; Wolter JM; Coon JS
Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
Ohnishi K; Ishikawa H
Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
